Trial Profile
Immunogenicity of factor-VIII/von-Willebrand factor in previously untreated patients with severe haemophilia-A.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2014
Price :
$35
*
At a glance
- Drugs Factor VIII/von Willebrand factor (Primary)
- Indications Haemophilia A
- Focus Pharmacodynamics
- 07 Jul 2014 New trial record